Zynerba (ZYNE) Stock Forecast for 2023 – 2026. Sell or Buy?
Last update: September 23, 2023 (07:37)
Sector: HealthcareThe share price of Zynerba Pharmaceuticals, Inc. (ZYNE) now
50/200 Day Moving Average: $0.857 / $0.558
This figure corresponds to the Average Price over the previous 50/200 days. For Zynerba stocks, the 50-day moving average is the support level today.
For Zynerba stocks, the 200-day moving average is the support level today.
Are you interested in Zynerba Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Zynerba stock price in 2023, 2024, 2025, 2026, 2027. How much will one Zynerba share be worth in 2023 - 2027?
When should I take profit in Zynerba stock? When should I record a loss on Zynerba stock? What are analysts' forecasts for Zynerba stock? What is the future of Zynerba stock? We forecast Zynerba stock performance using neural networks based on historical data on Zynerba stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Zynerba stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Zynerba shares. This happens once a day.
Sell or Buy Zynerba (ZYNE) stocks? Analytic Experts Forecasting...
We present you the most up-to-date and complete review of analytical trend forecasts and views on the ZYNE stock market. Experts share their opinions on what to expect from the … Read more
Revisiting Zynerba Pharmaceuticals
Historical and forecast chart of Zynerba stock
The chart below shows the historical price of Zynerba stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Zynerba stock price can be found in the table below.
Long-term forecasts by years.
Zynerba daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Sep 25 | 1.27 | 1.22 | 1.30 | 7.05 |
| Sep 26 | 1.32 | 1.29 | 1.34 | 3.84 |
| Sep 27 | 1.31 | 1.27 | 1.36 | 7.41 |
| Sep 28 | 1.27 | 1.23 | 1.29 | 5.20 |
| Sep 29 | 1.32 | 1.26 | 1.38 | 9.09 |
| Sep 30 | 1.35 | 1.32 | 1.38 | 4.53 |
| Oct 01 | 1.40 | 1.37 | 1.47 | 7.51 |
| Oct 02 | 1.40 | 1.37 | 1.45 | 5.44 |
| Oct 03 | 1.42 | 1.35 | 1.50 | 10.74 |
| Oct 04 | 1.39 | 1.34 | 1.44 | 7.36 |
| Oct 05 | 1.36 | 1.29 | 1.43 | 10.69 |
| Oct 06 | 1.44 | 1.36 | 1.49 | 9.40 |
| Oct 07 | 1.41 | 1.38 | 1.48 | 7.36 |
| Oct 08 | 1.37 | 1.34 | 1.43 | 7.18 |
| Oct 09 | 1.44 | 1.40 | 1.47 | 5.07 |
| Oct 10 | 1.44 | 1.40 | 1.48 | 5.77 |
| Oct 11 | 1.46 | 1.39 | 1.54 | 10.53 |
| Oct 12 | 1.55 | 1.50 | 1.59 | 6.51 |
| Oct 13 | 1.52 | 1.43 | 1.56 | 8.75 |
| Oct 14 | 1.44 | 1.38 | 1.49 | 7.99 |
| Oct 15 | 1.47 | 1.45 | 1.50 | 3.77 |
| Oct 16 | 1.42 | 1.36 | 1.49 | 9.87 |
| Oct 17 | 1.51 | 1.44 | 1.55 | 8.16 |
| Oct 18 | 1.54 | 1.47 | 1.59 | 8.28 |
| Oct 19 | 1.50 | 1.43 | 1.57 | 9.92 |
| Oct 20 | 1.59 | 1.54 | 1.63 | 5.86 |
| Oct 21 | 1.48 | 1.42 | 1.56 | 9.81 |
| Oct 22 | 1.43 | 1.41 | 1.51 | 6.82 |
| Oct 23 | 1.33 | 1.31 | 1.37 | 4.35 |
| Oct 24 | 1.30 | 1.26 | 1.35 | 7.01 |
Zynerba Daily Price Targets
Zynerba Stock Forecast 09-25-2023.
Forecast target price for 09-25-2023: $1.27.
Negative dynamics for Zynerba shares will prevail with possible volatility of 6.582%.
Pessimistic target level: 1.22
Optimistic target level: 1.30
Zynerba Stock Forecast 09-26-2023.
Forecast target price for 09-26-2023: $1.32.
Positive dynamics for Zynerba shares will prevail with possible volatility of 3.699%.
Pessimistic target level: 1.29
Optimistic target level: 1.34
Zynerba Stock Forecast 09-27-2023.
Forecast target price for 09-27-2023: $1.31.
Negative dynamics for Zynerba shares will prevail with possible volatility of 6.901%.
Pessimistic target level: 1.27
Optimistic target level: 1.36
Zynerba Stock Forecast 09-28-2023.
Forecast target price for 09-28-2023: $1.27.
Negative dynamics for Zynerba shares will prevail with possible volatility of 4.946%.
Pessimistic target level: 1.23
Optimistic target level: 1.29
Zynerba Stock Forecast 09-29-2023.
Forecast target price for 09-29-2023: $1.32.
Positive dynamics for Zynerba shares will prevail with possible volatility of 8.330%.
Pessimistic target level: 1.26
Optimistic target level: 1.38
Zynerba Stock Forecast 09-30-2023.
Forecast target price for 09-30-2023: $1.35.
Positive dynamics for Zynerba shares will prevail with possible volatility of 4.331%.
Pessimistic target level: 1.32
Optimistic target level: 1.38
ZYNE (ZYNE) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 1.34 | 1.23 | 1.52 | 18.96 |
| Nov. | 1.26 | 1.11 | 1.35 | 18.00 |
| Dec. | 1.18 | 1.11 | 1.25 | 11.53 |
Zynerba forecast for this year
Zynerba Stock Prediction for Oct 2023
An uptrend is forecast for this month with an optimal target price of $1.34271. Pessimistic: $1.23. Optimistic: $1.52
Zynerba Stock Prediction for Nov 2023
An downtrend is forecast for this month with an optimal target price of $1.26295. Pessimistic: $1.11. Optimistic: $1.35
Zynerba Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $1.17884. Pessimistic: $1.11. Optimistic: $1.25
Zynerba (ZYNE) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.14 | 1.09 | 1.31 | 16.86 |
| Feb | 1.08 | 0.96 | 1.19 | 19.43 |
| Mar | 1.03 | 0.91 | 1.18 | 22.85 |
| Apr | 1.14 | 1.04 | 1.30 | 20.52 |
| May | 1.15 | 1.00 | 1.27 | 21.73 |
| Jun | 1.24 | 1.14 | 1.35 | 15.43 |
| Jul | 1.15 | 1.02 | 1.20 | 15.42 |
| Aug | 1.00 | 0.87 | 1.07 | 18.43 |
| Sep | 0.94 | 0.83 | 0.99 | 16.22 |
| Oct | 0.89 | 0.83 | 0.94 | 11.57 |
| Nov | 0.99 | 0.92 | 1.10 | 16.27 |
| Dec | 1.06 | 0.94 | 1.15 | 18.15 |
Zynerba (ZYNE) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.11 | 0.98 | 1.24 | 21.18 |
| Feb | 1.05 | 1.00 | 1.16 | 13.34 |
| Mar | 1.20 | 1.03 | 1.33 | 22.42 |
| Apr | 1.41 | 1.29 | 1.50 | 14.22 |
| May | 1.37 | 1.26 | 1.44 | 12.55 |
| Jun | 1.44 | 1.32 | 1.56 | 15.27 |
| Jul | 1.51 | 1.41 | 1.71 | 17.37 |
| Aug | 1.28 | 1.17 | 1.44 | 18.57 |
| Sep | 1.22 | 1.10 | 1.33 | 17.81 |
| Oct | 1.24 | 1.18 | 1.35 | 12.88 |
| Nov | 1.34 | 1.17 | 1.48 | 21.35 |
| Dec | 1.45 | 1.31 | 1.62 | 19.15 |
Zynerba (ZYNE) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.19 | 1.07 | 1.33 | 19.92 |
| Feb | 1.28 | 1.14 | 1.47 | 22.34 |
| Mar | 1.27 | 1.14 | 1.45 | 21.62 |
| Apr | 1.38 | 1.24 | 1.52 | 18.51 |
| May | 1.62 | 1.55 | 1.71 | 9.17 |
| Jun | 1.79 | 1.59 | 2.00 | 20.14 |
| Jul | 1.92 | 1.77 | 2.04 | 13.04 |
| Aug | 2.00 | 1.73 | 2.14 | 19.07 |
| Sep | 2.18 | 1.92 | 2.44 | 21.27 |
| Oct | 2.09 | 1.79 | 2.35 | 23.86 |
| Nov | 2.38 | 2.30 | 2.59 | 11.41 |
| Dec | 2.75 | 2.39 | 2.99 | 20.21 |
Zynerba (ZYNE) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.26 | 2.17 | 2.54 | 14.73 |
| Feb | 1.96 | 1.76 | 2.16 | 18.58 |
| Mar | 1.95 | 1.86 | 2.12 | 12.45 |
| Apr | 2.09 | 1.90 | 2.32 | 17.87 |
| May | 2.45 | 2.28 | 2.59 | 12.23 |
| Jun | 2.28 | 2.14 | 2.39 | 10.64 |
| Jul | 2.38 | 2.09 | 2.53 | 17.16 |
| Aug | 2.59 | 2.41 | 2.96 | 18.57 |
| Sep | 2.87 | 2.69 | 2.98 | 9.56 |
| Oct | 2.95 | 2.54 | 3.09 | 17.68 |
| Nov | 2.90 | 2.68 | 3.28 | 18.17 |
| Dec | 3.41 | 3.26 | 3.57 | 8.75 |
Zynerba information and performance
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical company. The company is developing a new generation of synthetic cannabinoid therapeutic agents for transdermal administration.
80 W. LANCASTER AVENUE, SUITE 300, DEVON, PA, US
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
